Post Categories
Blog post not found!
Selecting a CRO for Chronic Disease Drug Development Using Small Molecules
Though not as buzzworthy as biologics or some other trendy therapies, small molecules (i.e., organic compounds with a low molecular weight) make up the…
Selecting a CRO for Chronic Disease Drug Development Using Small Molecules
April 1, 2020
Though not as buzzworthy as biologics or some other trendy therapies, small molecules (i.e., organic compounds with a low molecular weight) make up the…
Beauty and the Bacteria: Mechanical Forces in a Multispecies Biofilm Colony
Diverse, abundant microbial communities are found across all of the earth’s ecosystems, from the human intestinal tract to deep water hydrothermal vents to rainforest…
Beauty and the Bacteria: Mechanical Forces in a Multispecies Biofilm Colony
March 30, 2020
Diverse, abundant microbial communities are found across all of the earth’s ecosystems, from the human intestinal tract to deep water hydrothermal vents to rainforest…
Solanezumab Study Misses the Mark for the Fourth Time
Last month, American pharmaceutical company Eli Lilly ended its fourth study investigating the effectiveness of solanezumab, a potential drug therapy for people with mild cognitive…
Solanezumab Study Misses the Mark for the Fourth Time
March 17, 2020
Last month, American pharmaceutical company Eli Lilly ended its fourth study investigating the effectiveness of solanezumab, a potential drug therapy for people with mild cognitive…
CAR-T and CRISPR Cancer Trial Shows Promise
There is new hope for future innovation in the fast-moving field of cancer immunotherapy. Earlier this month, researchers from the University of Pennsylvania and…
CAR-T and CRISPR Cancer Trial Shows Promise
March 2, 2020
There is new hope for future innovation in the fast-moving field of cancer immunotherapy. Earlier this month, researchers from the University of Pennsylvania and…
Gene Therapy Innovation Strongly Encouraged by FDA with New Guidances
On January 28, 2020, the United States Food and Drug Administration (FDA) announced the release of six final guidances on gene therapy manufacturing and the…
Gene Therapy Innovation Strongly Encouraged by FDA with New Guidances
February 10, 2020
On January 28, 2020, the United States Food and Drug Administration (FDA) announced the release of six final guidances on gene therapy manufacturing and the…
5xFAD Mice Cleared of Tau and Amyloid Proteins Through Light and Sound
The 5xFAD mouse is a popular rodent model in the preclinical Alzheimer’s disease research community. Recently, research performed on 5xFAD mice benefited Shanghai-based company Green…
5xFAD Mice Cleared of Tau and Amyloid Proteins Through Light and Sound
February 3, 2020
The 5xFAD mouse is a popular rodent model in the preclinical Alzheimer’s disease research community. Recently, research performed on 5xFAD mice benefited Shanghai-based company Green…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
Introduction RNA based drugs are a promising new class of therapeutics with tremendous potential for treating a wide range of diseases. There are various…
NEWARK, Delaware, January 10, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a global contract research organization (CRO) that provides discovery, preclinical, bioanalysis, clinical trials,…
NEWARK, Delaware, Dec. 14, 2023/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a global contract research organization (CRO) that provides discovery, preclinical, bioanalysis, clinical trials,…
SPRINGFIELD, Missouri, Dec. 4, 2023/BUSINESS WIRE/ — QPS Holdings, LLC, a global contract research organization, has expanded operations in Springfield, Missouri. The new facilities…